Mulligan BioCapital
Europe, Hamburg, Germany, Hamburg
Description
Mulligan BioCapital is an investment firm dedicated to the life sciences with a specific focus on biotechnology with health care
Investor Profile
Mulligan BioCapital has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in Germany, Switzerland.
- Strong thematic focus on Biotechnology, Medical, Biopharma.
Stage Focus
- Series C (33%)
- Series A (33%)
- Series Unknown (17%)
- Seed (17%)
Country Focus
- Germany (83%)
- Switzerland (17%)
Industry Focus
- Biotechnology
- Medical
- Biopharma
- Therapeutics
- Biomass Energy
- Industrial
- Health Care
- Genetics
- Pharmaceutical
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Mulligan BioCapital frequently co-invest with?
What are some of recent deals done by Mulligan BioCapital?
Find More Investors Like Mulligan BioCapital
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides








